Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Byrna Technologies : Analyst Day Presentation

09/10/2021 | 12:52pm EDT


Cautionary Note Regarding Forward-Looking Statements

In addition to historical information, this presentation and other written reports and oral statements made from time to time by us may contain forward-looking statements. All statements, other than statements of

historical fact, included herein that address activities, events or developments that we expect or anticipate will or may occur in the future, are forward-looking statements. Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as "estimate", "plan", "anticipate", "expect", "imply", "intend", "believe", "project", "target", "budget", "may", "can", "will", "would", "could", "should", "seeks", or

"scheduled to", or other similar words, or negatives of these terms or other variations of these terms or comparable language or any discussion of strategy or intentions. Forward-looking statements address activities,

events or developments that the Company expects or anticipates will or may occur in the future and are based on current expectations and assumptions. Forward looking statements expressed or implied in this presentation include our growth, hiring and retention plans, production, sales and market expectations including final financial results for Q3, the full year and future periods, our models, margin projections and targets,

timing and success of new product introductions and expansion of distribution channels and customer base. These statements involve known and unknown risks, uncertainties, assumptions and other factors which may cause our actual results, performance or achievements to be materially different from any results, performance or achievements expressed or implied by such forward-looking statements.

Although the Company has attempted to identify important factors (including in the Risk Factors referenced below) that could cause actual results to differ materially from those described in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. Although these forward-looking statements were based on assumptions that the Company believes are reasonable when

made, you are cautioned that forward-looking statements are not guarantees of future performance and that actual results, performance or achievements may differ materially from those made in or suggested by the

forward-looking statements expressed or Implied in this presentation. Risks that could cause actual results to differ from those anticipated include disruption to production or the supply chain due to the ongoing pandemic, particularly new strains or otherwise that could disrupt product development or introduction, our production or distribution or those of our suppliers and negatively impact prices, production, profit and

revenues, our successful transition to managing production and sales of multiple products, our successful execution of plans to enter into new and potentially higher volume distribution channels, market response to our existing and new products, and our competitors' introduction of new products or execution of competing marketing strategies. In addition, even if Company results, performance, or achievements are consistent with the

forward-looking statements contained in this presentation, those results, performance or achievements may not be indicative of results, performance or achievements in subsequent periods. Given these risks and

uncertainties, you are cautioned not to place undue reliance on these forward-looking statements. Any forward-looking statements made in this presentation speak only as of the date of those statements, and the Company undertakes no obligation to update those statements or to publicly announce the results of any revisions to any of those statements to reflect future events or developments. Comparisons of results for current

and any prior periods are not intended to express any future trends or indications of future performance, unless expressed as such, and should only be viewed as historical data.

You should review "Risk Factors" contained in our Annual Report on Form 10-K for the year ended November 30, 2020, our Quarterly Report on Form 10-Q for the quarter ended May 31, 2021, and our other reports filed with

the Securities and Exchange Commission for more information about these and other risks. These risks may include the following and the occurrence of one or more of the events or circumstances alone or in combination with other events or circumstances, may have a material adverse effect on the Company's business, cash flows, financial condition and results of operations. Important factors and risks that could cause actual results to

differ materially from those in the forward-looking statements include, among others: risks related to Byrna's limited operating history on which the business can be evaluated; risks related to Byrna's history of operating

losses; risks related to Byrna's potential need for additional capital in the future to support operations and growth plans; risks related to whether Byrna can successfully implement its business plan for the sale of the Byrna HD; risk that revenue growth could be slower than expected and that the business, operating results and financial condition could be adversely affected; risks related to Byrna depending on the sale of the Byrna HD and

on maintaining and strengthening the Byrna brand; risks related to Byrna depending on third-party suppliers including sole source providers for certain components and for chemical irritant projectiles; risks related to Byrna being subject to extensive regulation, non-compliance with which could result in fines, penalties and other costs and liabilities; risks related to the potential delivery of products with defects, which may make Byrna

subject to product recalls or negative publicity, harm credibility, reduce market acceptance of Byrna products, and exposure the Company to liability; risks related to potential product liability lawsuits and other litigation

against Byrna which could cause Byrna to incur substantial liabilities and to limit commercialization of any products that may be developed in the future; risks related to the markets for security products and defense technology, which are in a state of technological change which could have a material adverse impact on Byrna's business, financial condition and results of operations; risks related to macroeconomics, such as general

economic conditions and epidemic and pandemic diseases (including the COVID-19 pandemic), could have a material adverse effect on Byrna's business, financial condition, results of operations, cash flows, and ability to comply with regulatory requirements; risks related to Byrna's performance being influenced by a variety of economic, social, and political factors; risks related to whether Byrna is able to protect its intellectual property,

which may cause it to lose a competitive advantage or incur substantial litigation costs to protect its rights; risks related to Byrna's trading market being limited, and the trading market for its common stock may not

develop or be sustained; risks related to Byrna's stock price, which may be volatile or may decline, including due to factors beyond Byrna's control.

Non-GAAP Financial Measures

In an effort to provide additional and useful information regarding Byrna's financial results and other financial information as determined by generally accepted accounting principles (GAAP), certain materials presented include non-GAAP information. A reconciliation of that information to GAAP and other related information is available in the supplemental material attached as an appendix to this presentation. These non-GAAP financial

measures are presented solely for informational and comparative purposes and should not be regarded as a replacement for corresponding GAAP measures..

Industry and Market Data

In this presentation, Byrna relies on and refers to information and statistics regarding Byrna and certain of its competitors and other industry data. The information and statistics are from third-party sources, including reports by market research firms.


This is an excerpt of the original content. To continue reading it, access the original document here.


Byrna Technologies Inc. published this content on 10 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 September 2021 16:51:03 UTC.

ę Publicnow 2021
10/18INSIDER BUY : Byrna Technologies
10/08BYRNA TECHNOLOGIES : 2. operations and management plans
10/08BYRNA TECHNOLOGIES : Reports Unchanged Fiscal Q3 Non-GAAP Net Loss Per Share; Revenue Doub..
10/08BYRNA TECHNOLOGIES INC. : Results of Operations and Financial Condition, Financial Stateme..
10/08Byrna Technologies Inc. Reports Earnings Results for the Third Quarter Ended August 31,..
10/08BYRNA TECHNOLOGIES : Reports FY 2021 Third Quarter Results
10/08BYRNA TECHNOLOGIES : Earnings Flash (BYRN) BYRNA TECHNOLOGIES Reports Q3 Revenue $8.7M, vs..
10/08BYRNA TECHNOLOGIES : Earnings Flash (BYRN) BYRNA TECHNOLOGIES Posts Q3 Loss $-0.04, vs. St..
10/04BYRNA TECHNOLOGIES INC. : Change in Directors or Principal Officers, Financial Statements ..
More news
Analyst Recommendations on BYRNA TECHNOLOGIES INC.
More recommendations
Financials (USD)
Sales 2021 41,1 M - -
Net income 2021 -1,91 M - -
Net Debt 2021 - - -
P/E ratio 2021 -162x
Yield 2021 -
Capitalization 408 M 408 M -
Capi. / Sales 2021 9,93x
Capi. / Sales 2022 6,80x
Nbr of Employees 169
Free-Float 70,0%
Duration : Period :
Byrna Technologies Inc. Technical Analysis Chart | BYRN | US12448X2018 | MarketScreener
Income Statement Evolution
Mean consensus BUY
Number of Analysts 3
Last Close Price 17,29 $
Average target price 32,17 $
Spread / Average Target 86,0%
EPS Revisions
Managers and Directors
Bryan Scott Ganz Chairman, President & Chief Executive Officer
David North Chief Financial Officer
AndrÚ Buys Chief Technology Officer
Michael Gillespie Chief Operating Officer
Paul C. Jensen Independent Director
Sector and Competitors
1st jan.Capi. (M$)
AIRBUS SE22.28%100 341